Nucleic Acid Aptamers for Diagnostics and Therapeutics: Global Markets

The Global market for aptamers was valued $10 million in 2009, this further increased to $236 million in 2010. Growing at a compound annual growth rate (CAGR) of 67.5%, this market is expected to be valued at nearly $1.8 billion by 2014.

Learn the break down of aptamer therapeutic markets by disease or application, including cardiovascular, cancer, macular degeneration, siRNA delivery, and infectious diseases through 2014…

Use this report to:

  • Receive analysis on all major known applications of aptamers in the biotechnology arena by identifying technology growth opportunities in aptamer use as adjuvants for SiRNA delivery, vaccines, and antisense technologies
  • Determine the specific applications and global market demand for nucleic acid aptamers for therapeutic and diagnostic purposes for a 5-year period from 2009 to 2014, divided by major disease type, and diagnostic applications (clinical, environmental, biodefense, etc.)
  • See 5-year forecasts and trends that due to significant investment in aptamer technology indicates that the therapeutic modality may remain important for some time to come
  • Understand the high growth and potential market segments of the nucleic acid aptamers for diagnostics and therapeutics market with a focus from 2009 through 2014.

To provide further information about this report we offer a Complimentary Introduction, available from our Website. To download, simply click here, go to the Table of Contents tab, add the complimentary introduction to your cart, and confirm your order.


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

%d bloggers like this: